Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count
- 18 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (17) , 2038-2041
- https://doi.org/10.1097/01.aids.0000191923.08938.5b
Abstract
The performance characteristics of the enzyme-linked immunospot assay (ELISPOT) assay (T-SPOT TB) for the diagnosis of latent tuberculosis infection in HIV-infected individuals are unknown. Given that ELISPOT enumerates Mycobacterium tuberculosis antigen-specific IFN-γ-secreting T cells, HIV-associated immunosuppression might adversely affect test performance. However, we found that 28 out of 29 HIV-positive individuals (97%) gave evaluable test results, and performance was independent of the CD4 T-cell count. ELISPOT test performance appears to be independent of HIV-associated immunosuppression.Keywords
This publication has 22 references indexed in Scilit:
- Effect of Routine Isoniazid Preventive Therapy on Tuberculosis Incidence Among HIV-Infected Men in South AfricaJAMA, 2005
- Utility of the antigen-specific interferon-?? assay for the management of tuberculosisCurrent Opinion in Pulmonary Medicine, 2005
- Outcome of HIV?Associated Tuberculosis in the Era of Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2004
- Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreakThe Lancet, 2003
- Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in UgandaAIDS, 2000
- Instability of Tuberculin and Candida Skin Test Reactivity in HIV-infected UgandansAmerican Journal of Respiratory and Critical Care Medicine, 1998
- A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1997
- Comparison of a Tuberculin Interferon‐γ Assay with the Tuberculin Skin Test in High‐Risk Adults: Effect of Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1997
- Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infectionThe Lancet, 1993
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989